While Varma is supportive of a shutdown, he said the medical damage to patients with other diseases is going to become insurmountable.
3 min read · 26 March 2020
PE firms move slowly into offense mode amid the coronavirus crisis and Thoma Bravo shelves its sale of Imprivata.
4 min read · 26 March 2020
While many traditional PE shops are busy assessing the potential impacts of covid-19 on their portfolios, a few are turning to their companies to develop vaccines and tests to curb the spread of coronavirus.
4 min read · 24 March 2020
Areas of the healthcare industry will likely be triggered into action, spurring innovation, as bottlenecks in the system become increasingly clear amid covid-19, says the venture and growth-equity investor.
3 min read · 23 March 2020
Imprivata, which helps healthcare providers protect patient information, was anticipated to command upwards of $2bn in a potential sale.
2 min read · 20 March 2020
Areas of the healthcare industry will likely be triggered into action, spurring innovation, as bottlenecks in the system become increasingly clear amid covid-19, Adams told PE Hub.
3 min read · 19 March 2020
Telehealth tackles the coronavirus and CapVest-backed Curium calls off its potential $3 billion sale.
4 min read · 19 March 2020
Barclays and Moelis have been engaged for sell-side financial advice, however the timeline of the process is unclear amid market uncertainty.
3 min read · 17 March 2020
As the JPM and Rothschild process for the French nuclear medicine company is put on hold, attention shifts to Webster Equity-backed PharmaLogic, sources told PE Hub.
2 min read · 17 March 2020
TSG Consumer makes a big splash in vet care amid other activity in the lower middle market, with L1 Health's Destination Pet buying VitalPet out of bankruptcy following Cortec's recent acquisition of Lap of Love.
3 min read · 15 March 2020
